4-Cyanophenyl isocyanate → (2R,5S)-4'-Cyano-4-(4-cyano-3-fluoro-5-methoxyphenyl)-2,5-dimethylpiperazine-1-carboxanilide
反応式
[CH3:1][C@H:2]1[CH2:7][NH:6][C@H:5]([CH3:8])[CH2:4][N:3]1[C:9]1[CH:16]=[C:15]([O:17][CH3:18])[C:12]([C:13]#[N:14])=[C:11]([F:19])[CH:10]=1.[N:20]([C:23]1[CH:30]=[CH:29][C:26]([C:27]#[N:28])=[CH:25][CH:24]=1)=[C:21]=[O:22]>C(#N)C>[C:27]([C:26]1[CH:29]=[CH:30][C:23]([NH:20][C:21]([N:6]2[CH2:7][C@H:2]([CH3:1])[N:3]([C:9]3[CH:16]=[C:15]([O:17][CH3:18])[C:12]([C:13]#[N:14])=[C:11]([F:19])[CH:10]=3)[CH2:4][C@H:5]2[CH3:8])=[O:22])=[CH:24][CH:25]=1)#[N:28]参加物
4
実験手順
Into 20 ml of acetonitrile was dissolved 500 mg of 4-[(2S,5R)-2,5-dimethylpiperazin-1-yl]-2-fluoro-6-methoxybenzonitrile, and then 274 mg of 4-isocyanatobenzonitrile was added thereto, followed by 1 hour of stirring at room temperature. The reaction solution was concentrated, followed by addition of ethyl acetate and filtration. The filtrate was removed by evaporation and the resulting powder was crystallized from hexane-ethyl acetate (85:15, v/v) to obtain 535 mg of the title compound.
後処理
- concentrationThe reaction solution was concentrated
- additionfollowed by addition of ethyl acetate and filtration
- customThe filtrate was removed by evaporation
- customthe resulting powder was crystallized from hexane-ethyl acetate (85:15, v/v)
出典と根拠
- ORDレコード
- ord-4c9f2f89438444b7864fa93af41233db
- 出典データセット
- uspto-grants-2010_02
- 特許番号
- US07666873B2
反応ノート
読み込み中…